Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A comment on optimal allocations for bioequivalence studies.

S Senn1, A P Grieve

  • 1Department of Epidemiology and Public Health, University College London, UK. stephens@public.health.ucl.ac.uk

Biometrics
|April 21, 2001
PubMed
Summary

A novel method for bioequivalence study allocations is statistically and practically flawed. This research details the reasons why the proposed allocation method is suboptimal for clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of humeral head osteochondrosis in the Greater Swiss Mountain dog and the Border Collie in Switzerland.

Schweizer Archiv fur Tierheilkunde·2016
Same author

A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial).

Revista portuguesa de pneumologia·2015
Same author

Cutaneous lymphocyte antigen and α4β7 T-lymphocyte responses are associated with peanut allergy and tolerance in children.

Allergy·2012
Same author

Visible iris sign as a predictor of problems during and following anterior approach ptosis surgery.

Eye (London, England)·2010
Same author

Statisticians and pharmacokineticists: what they can still learn from each other.

Clinical pharmacology and therapeutics·2010
Same author

[The German version of the satisfaction with stroke care questionnaire (SASC) for stroke patients].

Fortschritte der Neurologie-Psychiatrie·2010

Area of Science:

  • Pharmacometrics
  • Clinical Trial Design
  • Biostatistics

Background:

  • Bioequivalence studies are critical for generic drug approval.
  • Optimal allocation methods are essential for study efficiency and statistical power.
  • A recently proposed method aims to optimize subject allocation in these studies.

Discussion:

  • The proposed method's statistical underpinnings are shown to be unsound.
  • Practical implementation challenges render the method unfeasible in real-world settings.
  • The method's failure impacts the reliability and efficiency of bioequivalence assessments.

Key Insights:

  • The discussed allocation method does not achieve optimal subject distribution.
  • Statistical deficiencies compromise the validity of results derived from this method.

Related Experiment Videos

  • Practical limitations prevent its effective use in bioequivalence trials.

    • Outlook:

    • Revisiting fundamental statistical principles for allocation methods is necessary.
    • Development of robust and validated allocation strategies for bioequivalence studies is paramount.
    • Ensuring methodological rigor will enhance the integrity of pharmaceutical development.